ArticleInternational medical case reports journal2025
Atomoxetine-Induced Spontaneous Seminal Discharge in Adult ADHD With Trichotillomania: Case Report and Literature Review.
Article in International medical case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trichotillomania disorder is a psychiatric condition characterized by recurrent hair-pulling behaviors that result in substantial distress or impairment. Comorbidity between trichotillomania and adult attention-deficit/hyperactivity disorder (ADHD) is challenging, and an increasing body of evidence suggests a neurobiological overlap between the two conditions, particularly in the areas of executive functioning and inhibitory control. Atomoxetine is a selective norepinephrine reuptake inhibitor approved for ADHD by the Food and Drug Administration (FDA). It has been recommended for ADHD patients comorbid with anxiety disorders. Although most people can tolerate atomoxetine, there have been reports of uncommon side effects, such as sexual problems. This case report describes a 37-year-old man diagnosed initially with trichotillomania and generalized anxiety disorder and started on fluoxetine 20 mg for six weeks with substantial symptoms improvement of both disorders. Unfortunately, the patient exhibited increased impulsivity and irritability, which hindered his daily life functioning. Given this paradoxical response, fluoxetine was terminated. A multisession reassessment revealed lifelong ADHD with inattention, disorganization, emotional dysregulation, and impulsiveness. Consequently, Atomoxetine initiation/titration (25→75 mg) was attempted; however, he experienced spontaneous seminal discharge 6 weeks later. The assessment and workup included a normal urologic exam. We systematically evaluated potential infectious, inflammatory, and endocrine causes, checking testosterone, prolactin, LH/FSH, TSH, and urinalysis, all of which fell within the reference ranges. Subsequently, Atomoxetine was gradually withdrawn, and this rare side effect, seminal discharge, resolved within five days post-cessation of the medicine. After three months of monitoring, we re-evaluated ADHD and trichotillomania, adjusted the therapy, and observed that there was no recurrence of symptoms. This instance shows the importance of careful monitoring for rare side effects in people with complex psychiatric comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.